SCHEMBL24809762

SCHEMBL24809762

COc1nc(C2CCOC2)cn1C(=O)NCCC(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
HTR1A P08908 2/20 0.33
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
IRAK4 Q9NWZ3 4/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
USP2 O75604 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24810840 0.94 HTR1A (0.38) SMN1; SMN2HTR1ADRD2DRD4LMNA
SCHEMBL24810611 0.88 NAMPT (0.36) SMN1; SMN2LMNAHTTKDM4EALDH1A1
SCHEMBL24810647 0.86 ALDH1A1 (0.38) SMN1; SMN2LMNAHTTKDM4EALDH1A1
SCHEMBL24809746 0.85 ALDH1A1 (0.38) SMN1; SMN2LMNAHTTKDM4EALDH1A1
SCHEMBL24809767 0.84 NAMPT (0.40) HTR1ADRD2DRD4CNR2NAMPT
SCHEMBL24810658 0.82 TRPV3 (0.37) SMN1; SMN2HTR1ADRD2DRD4LMNA
SCHEMBL24809760 0.82 ASAH1 (0.47) NAMPT
SCHEMBL24810619 0.82 HPGD (0.40) SMN1; SMN2LMNAHTTKDM4EALDH1A1
SCHEMBL24809776 0.81 HPGDS (0.35) PDE4DSMN1; SMN2IRAK4NAMPTUCHL1
SCHEMBL24810732 0.80 PDE4D (0.31) PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411388-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL R&D INVEST S A (PT) 2022-12-29 US disclosed
EP-4031531-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411388-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GAA, CLN6 PDE4D 2308/4885SMN1; SMN2 79/4885HTR1A 2998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.